Allens has advised global merchant bank BDT & MSD Partners on its proposed $1.6 billion investment in Australian-headquartered health, pharmaceuticals and beauty corporation DBG Health.
The deal includes a potential follow-on investment of up to $1 billion, representing one of the largest private, founder-led transactions in Australia.
Allens collaborated with Sidley Austin in New York to advise on all aspects of the transaction.
'Private capital partnerships continue to play an instrumental role in unlocking growth opportunities in the health and consumer sectors,' said lead partner Michelle Bennett.
'We are pleased to have worked with BDT & MSD on this strategic investment, consistent with their focus on partnering with founder-led businesses with long-term investment horizons.'
Allens legal team
The Allens Core team was led by Michelle Bennett (Partner, M&A), Wendy Rae (Partner, M&A and FIRB), Craig Milner (Partner, Tax), Fiona Crosbie (Partner, Competition, Consumer, Regulatory), Mayuri Dharmakulasingam (Senior Associate, M&A), Karla Hodgson (Senior Associate, M&A), Vincent Pang (Managing Associate, M&A and FIRB), Nick Li (Senior Associate, Regulatory), Gabby Ong (Associate, M&A), Kevin Ren (Associate, M&A), Georgia Whiteside (Senior Associate Tax) and Edison Wang (Senior Associate, Competition).